POSITIVEID CORP COM USD0.01(POST REV SPLIT) (PSID)

0.03
0.00 5.00
OTC
Prev Close 0.03
Open 0.03
Day Low/High 0.03 / 0.03
52 Wk Low/High 0.03 / 2.20
Volume 2.68M
Exchange OTC
Shares Outstanding 38.65B
Market Cap 1.20M
Div & Yield N.A. (N.A)

Latest News

PositiveID To Launch Bluetooth Version Of Its Caregiver Non-Contact Thermometer By Early 2017

PositiveID To Launch Bluetooth Version Of Its Caregiver Non-Contact Thermometer By Early 2017

Bluetooth-enabled Caregiver will connect wirelessly to electronic health record systems and patient monitoring stations

PositiveID Corporation And ENSCO Awarded U.S. Department Of Homeland Security Contract For SenseNet Program Phase II

PositiveID Corporation And ENSCO Awarded U.S. Department Of Homeland Security Contract For SenseNet Program Phase II

Following successful completion of SenseNet Phase I, PositiveID and ENSCO have been selected for the Phase II contract

PositiveID Completes Acquisition Of Thermomedics And The Caregiver Non-Contact Thermometer

PositiveID Completes Acquisition Of Thermomedics And The Caregiver Non-Contact Thermometer

Since Assuming Control of Thermomedics, PositiveID has significantly expanded the distribution channel and sales and marketing for Caregiver

PositiveID Reports Q2 2016 Revenue Of $1.8 Million, Up From $51 Thousand In Q2 2015

PositiveID Reports Q2 2016 Revenue Of $1.8 Million, Up From $51 Thousand In Q2 2015

First Half 2016 Revenues Exceed $3.5 Million, Up from $182 Thousand in First Half 2015

PositiveID To Exhibit At The Military Health System Research Symposium August 15-18

PositiveID To Exhibit At The Military Health System Research Symposium August 15-18

PositiveID will feature its molecular diagnostics, mobile labs and medical device businesses

PositiveID Adds GenArraytion CEO R. Paul Schaudies, Ph.D. To Its Board Of Advisors

PositiveID Adds GenArraytion CEO R. Paul Schaudies, Ph.D. To Its Board Of Advisors

GenArraytion Developed the First Commercially Available, Multi-Target Zika Virus Assay, which PositiveID Implemented on Its Firefly Dx Prototype System and Successfully Detected the Zika Virus

PositiveID To Exhibit Its Caregiver Non-Contact Thermometer At The Association For Healthcare Resource And Materials Management Conference July 31-August 3

PositiveID To Exhibit Its Caregiver Non-Contact Thermometer At The Association For Healthcare Resource And Materials Management Conference July 31-August 3

The AHRMM exhibition draws more than 1,000 attendees and showcases the latest products to improve the effectiveness and efficiency of healthcare operations

PositiveID's Caregiver Non-Contact Thermometer Outperforms In Evidence-Based Study

PositiveID's Caregiver Non-Contact Thermometer Outperforms In Evidence-Based Study

Veterans Affairs San Diego Healthcare System PACU Nurses Prefer Caregiver over Temporal Artery Thermometer Due to Ease of Use

PositiveID Announces Highlights For First Half Of 2016

PositiveID Announces Highlights For First Half Of 2016

Highlights include increasing year-over-year revenues, achieving major Firefly Dx development milestone, and successful detection of Zika on the Firefly Dx prototype

PositiveID Announces Reverse Stock Split

PositiveID Announces Reverse Stock Split

Company to trade as PSIDD for 20 trading days

PositiveID's Thermomedics Wins Appeal In Patent Infringement Case In U.S. Court Of Appeals For The Federal Circuit

PositiveID's Thermomedics Wins Appeal In Patent Infringement Case In U.S. Court Of Appeals For The Federal Circuit

Thermomedics' Intellectual Property Found Not to Infringe on Exergen's Invalid Patent Claims

PositiveID's Mobile Lab Business Completed 80 Projects In The First Half Of 2016

PositiveID's Mobile Lab Business Completed 80 Projects In The First Half Of 2016

ENG's backlog and pipeline for the third quarter includes approximately 40 projects

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTC Markets Group, President and CEO R. Cromwell Coulson, will speak on panel "Understanding Reg A+ and the 'Mini IPO'"

PositiveID Adds Benedikt Von Braunmuhl To Its Board Of Advisors

PositiveID Adds Benedikt Von Braunmuhl To Its Board Of Advisors

Mr. von Braunmuhl has more than 20 years of experience with global healthcare companies, and will assist the Company's efforts to commercialize Firefly Dx to detect Zika and other pathogens

PositiveID Successfully Detects The Zika Virus On Its Firefly Dx Prototype System

PositiveID Successfully Detects The Zika Virus On Its Firefly Dx Prototype System

PositiveID uses assay partner GenArraytion's Zika test, the first commercially available multi-plexed PCR-based molecular test to identify dual lineages of the Zika virus

PositiveID Reports Q1 2016 Revenue Of $1.7 Million, Up From $0.1M In Q1 2015

PositiveID Reports Q1 2016 Revenue Of $1.7 Million, Up From $0.1M In Q1 2015

Significant improvement at the operating line driven by performance of the Company's mobile lab business

PositiveID To Exhibit Its Caregiver Non-Contact Thermometer At The American Association Of Critical-Care Nurses Exposition May 16-19

PositiveID To Exhibit Its Caregiver Non-Contact Thermometer At The American Association Of Critical-Care Nurses Exposition May 16-19

Caregiver, FDA-cleared for clinical use, reduces the risk of cross-contamination and costs for healthcare facilities

PositiveID Launches New Website For E-N-G Mobile Systems At Www.e-n-g.com

PositiveID Launches New Website For E-N-G Mobile Systems At Www.e-n-g.com

E-N-G is a leader in mobile labs for biological and chemical detection with more than 400 MobiLabs in the field

PositiveID's E-N-G Mobile Systems Ships Mobile Lab In Excess Of $700,000 To Customer

PositiveID's E-N-G Mobile Systems Ships Mobile Lab In Excess Of $700,000 To Customer

E-N-G has delivered more than 400 mobile labs to domestic and international customers

PositiveID Reports 2015 Revenue Of $2.9 Million, Up 211% Year Over Year

PositiveID Reports 2015 Revenue Of $2.9 Million, Up 211% Year Over Year

Total Assets Increase 360% to $4.7 Million

PositiveID Achieves Major Firefly Dx Development Milestone

PositiveID Achieves Major Firefly Dx Development Milestone

Newest milestone and lab results demonstrate Firefly Dx design is capable of full biological testing process, from sample preparation to PCR and detection